Drug Coated Balloons (DCB) are an “appealing treatment option” for large vessel coronary artery disease (CAD) with similar target lesion revascularization (TLR) and other cardiovascular outcomes during mid-term follow-ups compared with drug eluting stents (DES), according to a new meta-analysis.